Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase I/II Trial of Encorafenib, Cetuximab, and Nivolumab in Microsatellite Stable BRAFV600E Metastatic Colorectal Cancer (BMS-MDACC CA209-8P6/ARRAY IST-818-101X)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04017650
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:57.371156+00:00
Published At
2025-11-20T00:00:00+00:00
Record Updated At
2025-11-20
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["BRAF NP_004324.2:p.V600E", "Metastatic Colon Adenocarcinoma", "Metastatic Microsatellite Stable Colorectal Carcinoma", "Metastatic Rectal Adenocarcinoma", "Progressive Disease", "Recurrent Colorectal Carcinoma", "Stage III Colorectal Cancer AJCC v8", "Stage IIIA Colorectal Cancer AJCC v8", "Stage IIIB Colorectal Cancer AJCC v8", "Stage IIIC Colorectal Cancer AJCC v8", "Stage IV Colorectal Cancer AJCC v8", "Stage IVA Colorectal Cancer AJCC v8", "Stage IVB Colorectal Cancer AJCC v8", "Stage IVC Colorectal Cancer AJCC v8", "Unresectable Colon Adenocarcinoma", "Unresectable Rectal Adenocarcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-11-20"
protocolSection.identificationModule.nctId
"NCT04017650"
protocolSection.identificationModule.officialTitle
"Phase I/II Trial of Encorafenib, Cetuximab, and Nivolumab in Microsatellite Stable BRAFV600E Metastatic Colorectal Cancer (BMS-MDACC CA209-8P6/ARRAY IST-818-101X)"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • BRAF NP_004324.2:p.V600E (protocolSection.conditionsModule.conditions)
  • Metastatic Colon Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic Microsatellite Stable Colorectal Carcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic Rectal Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Progressive Disease (protocolSection.conditionsModule.conditions)
  • Recurrent Colorectal Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage III Colorectal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIIA Colorectal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIIB Colorectal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIIC Colorectal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Colorectal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVA Colorectal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVB Colorectal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVC Colorectal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Unresectable Colon Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Unresectable Rectal Adenocarcinoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.